IRS1 and cholangiocarcinoma: To elaborate the effect of IRS1 on the progression of CCA, the highly aggressive cancer cell lines with high expression of nuclear IRS1 and cytoplasmic IRS1 (KKU-213A and KKU-213B, respectively) were used for siRNA-mediated transient IRS1 knockdown.